The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration

QR Code

The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration

The paper presents the evaluation of Retinalamin efficacy administered intramuscularly to 90 patients (180 eyes) aged 47 to 75 (averagely, 65.9 ± 7.18 years) with various stages of dry age-related macular degeneration (AMD) once or twice in 6 months. The data of multifocal electroretinography (MfERG...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Neroev, O. V. Zaitseva, T. D. Okhotsimskaya, I. V. Tsapenko, E. P. Lantukh
Format:	Article
Language:	Russian
Published:	Real Time Ltd 2018-10-01
Series:	Российский офтальмологический журнал
Subjects:	цитомедины ретиналамин возрастная макулярная дегенерация лечение retinalamin® age-related macular degeneration treatment
Online Access:	https://roj.igb.ru/jour/article/view/7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration
by: I. B. Alekseev, et al.
Published: (2018-10-01)

The results of a long-term follow up of patients with age-related macular degeneration who received a lutein-containing medication
by: O. V. Zaytseva, et al.
Published: (2018-10-01)

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

THE PROGNOSTIC VALUE OF PHARMACOLOGICAL AND GENETIC TESTING IN MEDICAL THERAPY OF AGE-RELATED MACULAR DEGENERATION
by: N. A. Bakunina, et al.
Published: (2018-10-01)

Clinical effectiveness of nutrof total supplement for Dry age-related macular Degeneration
by: E. N. Eskina, et al.
Published: (2018-10-01)

Functional express testing and self monitoring in the diagnosis and treatment of macular diseases
by: S. O. Milyutkina, et al.
Published: (2018-10-01)

EXPERIENCE OF APPLICATION OF COMPLEX TREATMENT OF SENILE MACULAR DEGENERATION
by: A. A. Bessonov, et al.
Published: (2014-02-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
by: M. M. Bikbov, et al.
Published: (2019-08-01)

Electrophysiological signs of retinal cone remodeling in geographic atrophy of the pigment epithelium in patients with non-exudative age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-09-01)

LONG-TERM OUTCOMES OF RETINAL DEGENERATIVE DISORDER TREATMENT WITH PEPTIDE BIOREGULATORS
by: M. I. Razumovskiy, et al.
Published: (2015-07-01)

CYTOKINES IN LACRIMAL FLUID AND BLOOD SERUM: EARLY BIOMARKERS OF AGE-RELATED MACULAR DEGENERATION
by: O. S. Slepova, et al.
Published: (2015-06-01)

The role of free-radical processes in the pathogenesis of age-related macular degeneration. Review
by: A. V. Kolesnikov, et al.
Published: (2014-07-01)

ROLE OF DIETARY SUPPLEMENTATION IN PREVENTING PROGRESSION OF AGE-RELATED MACULAR DEGENERATION
by: N. A. Ermakova
Published: (2016-09-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01)

PERIPHERAL BLOOD SUBPOPULATION OF LYMPHOCYTES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
by: N. V. Balatskaya, et al.
Published: (2015-10-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Age-related macular degeneration associated with optic disc drusen
by: Anas Alkhabaz, et al.
Published: (2025-07-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

AGE- MACULAR DEGENERATION AND GLAUCOMA. EPIDEMIOLOGICAL AND CLINIC-PATHOGENETIC ASPECTS
by: A. Z. Fursova, et al.
Published: (2019-02-01)

Semantic analysis of social media messages of patients with neovascular age-related macular degeneration and diabetic macular edema by open Internet sources — a study of patients' opinions in real clinical practice
by: V. V. Neroev, et al.
Published: (2023-03-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

The Significance of Screening Questionnaire in the Evaluation of Age-Related Macular Risk Degeneration Development
by: L. A. Kochmasheva, et al.
Published: (2019-12-01)

Influence of fractal photostimulation on electroretinogram in patients with dry age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2025-06-01)

An integrated analysis of clinical and morphometric indications of atrophic forms of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2022-01-01)

Our Experience of Nutraceutical Effects in Age-Related Macular Degeneration
by: S. V. Yanchenko, et al.
Published: (2020-12-01)

The Use of Nutraceuticals in Patients with “Dry” Form of Age-Related Macular Degeneration on the Background of Accelerated Aging
by: S. A. Korotkih, et al.
Published: (2019-06-01)

The results of diagnostic and treatment of patients with diabetic retinopathy and age-related macular degeneration at a diabetes type 2.
by: I. V. Vorobyova, et al.
Published: (2014-10-01)

Experiences of treatment of age related macular degeneration with concomitant myopia
by: I. B. Alekseev, et al.
Published: (2019-03-01)

Genetic Risk and OCT-Based Phenotypic Associations in Age-Related Macular Degeneration
by: Shlomit Jaskoll, et al.
Published: (2025-11-01)

Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review
by: A. N. Kulikov, et al.
Published: (2023-10-01)

The efficiency of surgical and laser treatment of the age-related macular degeneration wet form
by: Yu. I. Khoroshikh, et al.
Published: (2011-08-01)

Screening of cytokines in blood serum and lacrimal liquid in wet and atrophic forms of age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2022-03-01)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

Melatonin level as a risk factor for age-related macular degeneration
by: N. S. Khodzhaev, et al.
Published: (2021-08-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Molecular Mechanisms of Druze Formation in the Retina in Age-Related Macular Degeneration
by: E. F. Barinov
Published: (2020-11-01)

Does uveitis increase the risk of age-related wet macular degeneration? A Mendelian randomization study
by: Rui-Hua Jing, et al.
Published: (2025-08-01)

Efficacy of the drug Vitalux Plus of patients with dry form of age-related macular degeneration
by: I. R. Gazizova, et al.
Published: (2014-07-01)

Mixed (combined) phenotype of the late stage of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-06-01)